NCT03024424View on ClinicalTrials.gov

Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 10, 2017

Study Completion Date

August 10, 2017

Conditions
Age-Related Macular DegenerationChoroidal NeovascularizationGenetic Counseling
Interventions
BEHAVIORAL

Early disclosure

BEHAVIORAL

Late disclosure

Trial Locations (1)

84132

University of Utah John A. Moran Eye Center, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT03024424 - Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD | Biotech Hunter | Biotech Hunter